Naloxone: What You Need to Know About Overdose Reversal In the Midst of an Opioid Epidemic

Size: px
Start display at page:

Download "Naloxone: What You Need to Know About Overdose Reversal In the Midst of an Opioid Epidemic"

Transcription

1 Naloxone: What You Need to Know About Overdose Reversal In the Midst of an Opioid Epidemic Kyle Troksa, Pharm.D., AE-C PGY1 Resident Community Medical Center March 4th, 2018

2 Conflicts of Interest No conflicts of interest to disclose Accolades Sherrill Brown, Pharm.D., DVM, BCPS University of Montana Skaggs School of Pharmacy Community Medical Center

3 Objectives 1. Assess scenarios in which naloxone may be administered or prescribed and how to educate patients and providers about its use 2. Analyze similarities and differences amongst naloxone products, resources regarding their use, and current/future applications

4 Pre-Question #1 What is the mechanism of action of naloxone and common side effects associated with its use? A. Non-competitive opioid antagonist / agitation, hypotension, tachycardia B. Competitive, partial opioid agonist / sedation, hypertension, bradycardia C. Competitive opioid antagonist / agitation, hypertension, tachycardia D. Non-competitive, full opioid agonist / sedation, hypotension, bradycardia

5 Pre-Question #2 You are the first responder to what was called in as an overdose. The patient is lying on the ground, has constricted pupils, slurred speech, normal breathing and responds to your questions. What is an appropriate action to take? A. Administer one dose of IN naloxone B. Administer two sequential naloxone doses ASAP C. Call EMS and monitor patient for worsening symptoms D. Call law enforcement to arrest patient

6 Pre-Question #3 A patron comes to you concerned that they will have legal repercussions for calling 911 for their friend who recently overdosed on opioids. What would be your best response? A. Find a good lawyer B. You are covered under the Good Samaritan Law C. Talk to your state representative D. Discuss the matter with your friend first to see if they want to press charges

7 Pre-Question #4 How soon after the first naloxone dose is given can another be administered if no response? A. 2-5 minutes B minutes C minutes D minutes E minutes

8 Pre-Question #5 A Russian speaking patient with no health insurance is requesting a recommendation for naloxone product to treat opioid overdose for her mother in the event it is needed. What is the best product to recommend? A. Intranasal Spray B. Intranasal Syringe C. Intramuscular Autoinjector D. A or B E. B or C

9 Agenda What is the landscape of the opioid epidemic? What is naloxone and its role in therapy? What are the differences in naloxone products? Who can give or receive naloxone? How do you administer naloxone? What are the access laws? What are resources available to providers/patients?

10 The Opioid Epidemic- Global

11 The Opioid Epidemic- National 115 Americans die daily from opioid overdose Economic burden: $78.5 Billion annually 2015: 33,000 deaths, 2M opioid related substance use disorders (likely more) 80% of people who use heroin tend to first abuse prescription opioids Epidemic designation from President Trump in 2017 drugabuse.gov

12 The Opioid Epidemic- National

13 The Opioid Epidemic- National

14 This image cannot currently be displayed.

15 This image cannot currently be displayed.

16 The Opioid Epidemic- Montana This image cannot currently be displayed. Not as bad as national average Between 2000 and 2015, 700 people in MT died of overdoses Pain protocols and limiting discharge opioids could be contributing to benefit Still room for improvement

17 Naloxone Brand names: Narcan, Evzio Mechanism of Action: competitive, pure opioid antagonist (mainly targets μ-opioid receptors) Onset- 2-5 min Duration min Absorption- IN, IM, SC, IV Distribution- weakly albumin bound, crosses BBB Metabolism- hepatic (glucuronidation) Excretion- urine Lexicomp

18 This image cannot currently be displayed. Harm Reduction Coalition

19 Naloxone Adverse reactions (immediate withdrawal): HTN, tachycardia, agitation, dizziness, headache, irritability, seizure, hot flash, abdominal cramps, vomiting, muscle spasm/pain, yawning Injection site reaction Pregnancy risk factor: C (crosses placenta) Breastfeeding: unknown if present in breast milk (lipophilic, so likely) Lexicomp

20 prescribetoprevent.org

21 This image cannot currently be displayed. prescribetoprevent.org

22 Shelf Life Store at RT (59 F-77 F), excursions 39 F-104 F allowed for up to 24 hours months (if stored properly, can use until expiration date) Once naloxone vial/amp is inserted into syringe, expires in 2 weeks Monitor expiration date- as last resort, can use expired product, but will likely not be as effective Naloxone Package Insert

23 Signs of an overdose HIGH OVERDOSE Pupils constricted Muscles relaxed Responsive to stimulus Pruritus (scratch at skin) Slurred speech Harm Reduction Coalition Awake, but unable to talk Limp body Pale skin Cyanosis Respiratory depression Bradycardia Choking sounds Vomiting Loss of consciousness Unresponsive to outside stimulus

24 This image cannot currently be displayed. prescribetoprevent.org

25 Who can access or administer naloxone Law enforcement Emergency departments Parents/siblings/friends Firefighters School administration Senior centers Military personnel etc. This image cannot currently be displayed.

26 Approach to Treating an Overdosed Patient SCARE ME: Stimulation Call 911 Airway Rescue Breathing Evaluate the Situation Muscular Injection (or intranasal) Evaluate Again This image cannot currently be displayed. Harm Reduction Coalition

27 Administration- Intranasal Spray How supplied: 4 mg/0.1 ml 2 pack single spray device Sig: Spray entire contents of device into 1 nostril upon signs of opioid overdose. Call 911 May repeat x1 in other nostril This image cannot currently be displayed. CPNP Naloxone Access Guideline

28 This image cannot currently be displayed. Administration- Intranasal Spray Narcan Package Insert

29 Administration- Intranasal Syringe How supplied: 2 mg/2 ml 2 pack syringes Also need Rx for atomizer No. 2 Sig: One spray into each nostril upon signs of opioid overdose. Call 911 May repeat x1. This image cannot currently be displayed. CPNP Naloxone Access Guideline

30 Administration- Intranasal Syringe CPNP Naloxone Access Guideline

31 Administration- Intramuscular Vials How supplied: 0.4 mg/ml 2 pack single dose vial Need Rx for 3 ml x 25G 1 in. No. 2 Sig: Inject 1 ml IM upon signs of opioid overdose. Call 911 May repeat x1. This image cannot currently be displayed. CPNP Naloxone Access Guideline

32 Administration- Intramuscular Vials CPNP Naloxone Access Guideline

33 Administration- Intramuscular Auto Injector How supplied: 0.4 mg/0.4 ml 2 pack Sig: Inject IM into outer thigh upon signs of opioid overdose. Listen to English prompts--hold in place for 5 seconds. Call 911 May repeat x1. CPNP Naloxone Access Guideline

34 Administration- Intramuscular Auto Injector This image cannot currently be displayed. EVZIO Package Insert

35 Insurance Coverage Cost: Intranasal spray- $75.00 Intranasal syringe- $39.60 Intramuscular vials- $18.71 Intramuscular autoinjector- $2, Coverage: CMS and private plans will pay for naloxone. Atomizer typically not covered (provided free or $10 for 2 atomizers). CPNP Naloxone Access Guideline

36 Access Laws Good Samaritan Laws MT-HB 333: Help Save Lives From Overdose Act Immunity from legal prosecution for calling for help Standing Orders (to be discussed by Dr. John Douglas) Allows for increased access to naloxone without prescription Liability protection/third party administration: Protects prescriber, pharmacist, and naloxone administrator CPNP Naloxone Access Guideline

37 Resources CPNP Naloxone Access Guide Project Lazarus Community Toolkit

38 Resources Drug Take-back Days 1-2 times per year- patients can bring unused/expired medications for disposal Rx drop-boxes Missoula Police Department Granite Pharmacy Other takeback centers:

39 Post-Question #1 What is the mechanism of action of naloxone and common side effects associated with its use? A. Non-competitive opioid antagonist / agitation, hypotension, tachycardia B. Competitive, partial opioid agonist / sedation, hypertension, bradycardia C. Competitive opioid antagonist / agitation, hypertension, tachycardia D. Non-competitive, full opioid agonist / sedation, hypotension, bradycardia

40 Post-Question #2 You are the first responder to what was called in as an overdose. The patient is lying on the ground, has constricted pupils, slurred speech, normal breathing and responds to your questions. What is an appropriate action to take? A. Administer one dose of IN naloxone B. Administer two sequential naloxone doses ASAP C. Call EMS and monitor patient for worsening symptoms D. Call law enforcement to arrest patient

41 Post-Question #3 A patron comes to you concerned that they will have legal repercussions for calling 911 for their friend who recently overdosed on opioids. What would be your best response? A. Find a good lawyer B. You are covered under the Good Samaritan Law C. Talk to your state representative D. Discuss the matter with your friend first to see if they want to press charges

42 Post-Question #4 How soon after the first naloxone dose is given can another be administered if no response? A. 2-5 minutes B minutes C minutes D minutes E minutes

43 Post-Question #5 A Russian speaking patient with no health insurance is requesting a recommendation for naloxone product to treat opioid overdose for her mother in the event it is needed. What is the best product to recommend? A. Intranasal Spray B. Intranasal Syringe C. Intramuscular Autoinjector D. A or B E. B or C

44 Preguntas? This image cannot currently be displayed.

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Background: In September 2015, Illinois passed a new law, PA99-0480, expanding access to the opioid

More information

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Clint Ross, PharmD, BCPP Clinical Pharmacy Specialist Psychiatry Residency Program Director Psychiatric Pharmacy Medical University

More information

Naloxone Standing Order for Opioid Overdose

Naloxone Standing Order for Opioid Overdose Naloxone Standing Order for Opioid Overdose By: Christine Trusky, PharmD Candidate 2016, Wilkes University Continuing Education Activity Details: Activity Type: Knowledge-based Target Audience: Pharmacists

More information

Opioid Harm Reduction

Opioid Harm Reduction Opioid Harm Reduction Lucas G. Hill, PharmD Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy Clinical Pharmacist, CommUnityCare FQHCs Director, Operation Naloxone Mark

More information

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no THE SOUTH CAROLINA BOARD OF MEDICAL EXAMINERS AND THE SOUTH CAROLINA BOARD OF PHARMACY S JOINT PROTOCOL TO INITIATE DISPENSING OF NALOXONE HCI WITHOUT A PRESCRIPTION This joint protocol authorizes any

More information

PL CE LIVE: Overdose Prevention with Naloxone Opportunities for Pharmacists May 2015

PL CE LIVE: Overdose Prevention with Naloxone Opportunities for Pharmacists May 2015 PL CE LIVE: Overdose Prevention with Naloxone Opportunities for Pharmacists May 2015 Supplemental Information Background Most people who abuse prescription opioids get them for free from a friend or relative

More information

Protocol For: Personally Furnishing Naloxone. Update Log

Protocol For: Personally Furnishing Naloxone. Update Log Protocol For: Personally Furnishing Naloxone Update Log Updated By: Reason for Update: Date: Approved By: K. Benick RN Original draft 6/7/16 Pam Butler Protocol: Personally Furnishing Naloxone_Morrow County

More information

How to Save a Life: Naloxone for the Treatment of Opioid Overdose

How to Save a Life: Naloxone for the Treatment of Opioid Overdose How to Save a Life: Naloxone for the Treatment of Opioid Overdose Brandon Antinopoulos, PharmD PGY1 Community Practice Resident University of Pittsburgh School of Pharmacy & Pennsylvania Pharmacists Association

More information

Naloxone. Medical Uses. Opiate overdose. From Wikipedia, the free encyclopedia. Naloxone

Naloxone. Medical Uses. Opiate overdose. From Wikipedia, the free encyclopedia. Naloxone Naloxone From Wikipedia, the free encyclopedia Naloxone Naloxone, sold under the brandname Narcan among others, is a medication used to reverse the effects of opioids, especially in overdose. [2] Naloxone

More information

Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City

Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City Section 1: Purpose Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City As some of health care s most accessible practitioners, pharmacists are uniquely positioned

More information

NALOXONE: HEALTHCARE PROFESSIONALS TRAINING GUIDE FOR ADMINISTRATION AND DISPENSING

NALOXONE: HEALTHCARE PROFESSIONALS TRAINING GUIDE FOR ADMINISTRATION AND DISPENSING NALOXONE: HEALTHCARE PROFESSIONALS TRAINING GUIDE FOR ADMINISTRATION AND DISPENSING Kaitlyn Bernard, PharmD PGY-1 Pharmacy Practice Resident November 18, 2017 Objectives Explain the impact of the opioid

More information

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health Protecting, Leading, Uniting Since 1893 Law Enforcement Naloxone Training Florida Department of Children and Families Office of Substance Abuse and Mental Health 1. Learn how to recognize and respond to

More information

Naloxone Administration Training

Naloxone Administration Training Naloxone Administration Training Welcome! Welcome to the online training for naloxone administration The Presenter Dr. Joe Parks, Medical Director, Distinguished Professor, Missouri Institute for Mental

More information

Pennsylvania DEPARTMENT OF HEALTH

Pennsylvania DEPARTMENT OF HEALTH Pennsylvania DEPARTMENT OF HEALTH Updated: 01/10/2018 XI. XII. KEY INFORMATION 1. If you believe, someone is experiencing an opioid overdose, call 911! 2. Remain with the person until first responders

More information

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING Opioid Epidemic Prescription Opiods Can be prescribed by doctors to treat moderate to severe pain, but can also have serious risks and side

More information

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017 EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. Course Outline Introduction and Overview

More information

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties Naloxone Statewide Standing Order Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties Objectives Review the US & NC trends on opioid overdose Understand key

More information

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 1 2 EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 3 4 5 6 Course Outline Introduction

More information

Naloxone Information for Community Pharmacies in Georgia: What You Need to Know

Naloxone Information for Community Pharmacies in Georgia: What You Need to Know Naloxone Information for Community Pharmacies in Georgia: What You Need to Know Your pharmacy may start receiving an increased volume of prescriptions for naloxone (Narcan ) due to legal changes in 2014.

More information

3/19/18. Background. School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools. Background

3/19/18. Background. School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools. Background School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools Rodrick J. Marriott, PharmD Director, Drug Control Division Background Background Overdose deaths involving prescription

More information

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Alexander Y. Walley, MD, MSc Boston University School of Medicine ThINC Bergen 2015 Conference

More information

Addressing the Opioid Epidemic Naloxone and its Role in Prevention of Opioid Overdose Death May 24, 2018

Addressing the Opioid Epidemic Naloxone and its Role in Prevention of Opioid Overdose Death May 24, 2018 Addressing the Opioid Epidemic Naloxone and its Role in Prevention of Opioid Overdose Death May 24, 2018 Five Pillars Today s Speaker Elizabeth Skoy, PharmD Associate Professor of Pharmacy Practice North

More information

POWER TO HELP REVERSE AN OPIOID OVERDOSE

POWER TO HELP REVERSE AN OPIOID OVERDOSE POWER TO HELP REVERSE AN OPIOID OVERDOSE FDA APPROVED Concentrated 4 mg dose Needle-free; no assembly required Designed for ease-of-use in the community setting Requires no specialized training* Not a

More information

Role of the Pharmacist: Naloxone Training. Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy

Role of the Pharmacist: Naloxone Training. Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy Role of the Pharmacist: Naloxone Training Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy Disclosure Kathleen Besinque Nothing to disclose. Objectives: After attending

More information

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance Naloxone for Emergency Administration: A 2017 Update On FDA Guidance Nathan A. Painter, PharmD, CDE Associate Clinical Professor University of California San Diego Skaggs School of Pharmacy and Pharmaceutical

More information

Opiate Overdose Treatment: Naloxone Training Protocol

Opiate Overdose Treatment: Naloxone Training Protocol OREGON STATE PUBLIC HEALTH DIVISION EMS & Trauma Systems Kate Brown, Governor September 22, 2016 For more information, contact David Lehrfeld, MD, Medical Director, EMS & Trauma Systems: (971) 673-0520

More information

NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE

NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE Stephanie Nichols, PharmD, BCPS, BCPP Associate Professor, Husson University Nicholss@husson.edu Why did you become a pharmacy professional?

More information

Revised 16 February, of 7

Revised 16 February, of 7 341 State Street Suite G Madison, WI 53703 ph: (608) 251 4454 f: (608) 251 3853 6333 University Avenue, Middleton WI 53562 ph: (608) 310 5389 f: (608) 285 9603 INTRANASAL OR INTRAMUSCULAR NALOXONE PROTOCOL:

More information

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded access to naloxone, overdose education, prevention,

More information

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE NARCAN: THE HISTORY, APPLICATIONS AND FUTURE TABLE OF CONTENTS 3 Intro 4 What is Naloxone? 8 How Naloxone is Administered 12 Where to Find Narcan in California The United States accounts for about five

More information

OVERDOSE IN UTAH PREVENTION AND RESPONSE. Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017

OVERDOSE IN UTAH PREVENTION AND RESPONSE. Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017 OVERDOSE IN UTAH PREVENTION AND RESPONSE Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017 Questions How many people have known someone who has experienced an overdose? How many

More information

Pharmacist Directed Opioid Antagonist Dispensing

Pharmacist Directed Opioid Antagonist Dispensing Pharmacist Directed Opioid Antagonist Dispensing MARK BOESEN, PHARM.D., J.D. CHAIRMAN AND CEO GENRX PHARMACY C0-CHAIRMAN ARIZONA PHARMACY ASSN. LEGISLATIVE COMMITTEE DECEMBER 15, 2016 Opioid Substance

More information

Substance Misuse and Abuse

Substance Misuse and Abuse CHAPTER 18 Substance Misuse and Abuse Lesson Objectives 1. Explain actions that can be taken to help prevent youth from abusing drugs and other substances. 2. Describe specific steps for preventing someone

More information

NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE

NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE WHAT IT IS WHAT IT IS NARCAN (naloxone HCl) Nasal Spray is the first and only FDA-approved nasal form of naloxone for the emergency treatment of a known

More information

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY Administration of Naloxone for Opiate Overdose Disclaimer: Authorization - EMT Optional Skills Only authorized Emergency Medical Technicians (EMT) who

More information

Naloxone and Combating the Opioid Epidemic

Naloxone and Combating the Opioid Epidemic Objectives Naloxone and Combating the Opioid Epidemic Jeff Jacobson PharmD Southpointe Pharmacy Discuss the current opioid crisis Define the role of Naloxone in opioid overdose Analyze the barriers to

More information

Drug Class Review: Opioid Reversal Agents

Drug Class Review: Opioid Reversal Agents Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Pharmacist Learning Objectives

Pharmacist Learning Objectives Opioid Overdose Education and Naloxone Distribution Keith Thornell, Pharm.D. Clinical Pharmacist Co-Occurring Disorders Pain Clinic NM Veterans Affairs Health Care System richard.thornell@va.gov 1 Pharmacist

More information

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS Overview The goal of this presentation is to help inform the public safety community of North Carolina

More information

Anyone Can Become Addicted. Anyone.

Anyone Can Become Addicted. Anyone. Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.

More information

Prescribing Naloxone to Patients for Overdose Reversal

Prescribing Naloxone to Patients for Overdose Reversal Prescribing Naloxone to Patients for Overdose Reversal Module Author: Julie Kmiec, DO Assistant Professor of Psychiatry, University of Pittsburgh School of Medicine Addiction Psychiatry - Western Psychiatric

More information

Braintree Public Schools

Braintree Public Schools Braintree Public Schools Policy and Procedures for School Nurse, Athletic Director and Athletic Trainer Management of Potential Life Threatening Opioid Overdose Program Policy In order to recognize and

More information

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services #1 TITLE SLIDE #2 INTRODUCTION AND PURPOSE Welcome to Overdose

More information

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, 2018 2 Objectives: qreview names of different types of opioids qidentify the signs and symptoms

More information

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies October 20, 2016 Scott K. Proescholdbell, MPH Opioid Overdose and North Carolina s Public Health and Prevention Strategies Deaths per 100,000 population Death Rates* for Three Selected Causes of Injury,

More information

Naloxone Opioid Rescue Kits. Aaron Kochar, JD

Naloxone Opioid Rescue Kits. Aaron Kochar, JD Naloxone Opioid Rescue Kits Aaron Kochar, JD Common Opioids Codeine Lorcet Demerol Vicodin Oxycontin Hydrocodone Methadone Used as a Medication- Assisted Treatment Liquid methadone (difficult to divert/abuse)

More information

????? PL CE LIVE Special Edition: Overdose Prevention with Naloxone Opportunities for Pharmacists. Objectives. Questions We ll Answer Today

????? PL CE LIVE Special Edition: Overdose Prevention with Naloxone Opportunities for Pharmacists. Objectives. Questions We ll Answer Today Objectives PL CE LIVE Special Edition: Overdose Prevention with Naloxone Opportunities for Pharmacists May 5, 2015 Describe the impact of naloxone in preventing opioid overdoses and deaths. Identify three

More information

Substance Misuse and Abuse

Substance Misuse and Abuse CHAPTER 18 Substance Misuse and Abuse Lesson Objectives 1. Explain actions that can be taken to help prevent youth from abusing drugs and other substances. 2. Describe specific steps for preventing someone

More information

Opioid Use Disorders &Medication Treatment

Opioid Use Disorders &Medication Treatment Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review

More information

First Responder Naloxone Grant Webinar

First Responder Naloxone Grant Webinar First Responder Naloxone Grant Webinar December 22, 2014 Sarah Ruiz, MSW, Project Manager Naloxone Pilot Program, Massachusetts Department of Public Health Dr. Alexander Walley, MD, MSc, Assistant Professor

More information

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids Emily Junck, MD Hayes Wong, MD Paul Freeman, MD Special Guest: Caleb Banta-Green, PhD, MPH, MSW Special

More information

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD Skills and Knowledge on Overdose Prevention Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD Harm Reduction Coalition POLICY & ADVOCACY TRAINING & CAPACITY BUILDING OVERDOSE PREVENTION & ADVOCACY

More information

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89 HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89 In compliance with CMA regulation, I attest that I have no conflicts of interest associated

More information

Dosage. Hospira Mylan Amphastar Amphastar syringe Teleflex (nasal adapter) 0.4 mg/ml 4 mg/10 ml. 1mg/mL (2mg/2mL) Nov (b)(2) Narcan Nasal

Dosage. Hospira Mylan Amphastar Amphastar syringe Teleflex (nasal adapter) 0.4 mg/ml 4 mg/10 ml. 1mg/mL (2mg/2mL) Nov (b)(2) Narcan Nasal August 2016 DoD Drug Class Review: Alcohol Deterrents Narcotic Antagonists Page 1 of 6 Alcohol Deterrents Narcotic Antagonists Narcotic Antagonists Overview Drug overdose accounts for the leading cause

More information

Naloxone (Narcan) Initiatives and the Court System

Naloxone (Narcan) Initiatives and the Court System Naloxone (Narcan) Initiatives and the Court System Jolene Defiore-Hyrmer, Section Chief Violence and Injury Prevention Section 2018 Specialized Docket Conference October 12, 2018 2:45-4:00 Learning Objectives

More information

Clinical Policy: Naloxone (Evzio) Reference Number: CP.PMN.139 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid

Clinical Policy: Naloxone (Evzio) Reference Number: CP.PMN.139 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid Clinical Policy: Naloxone (Evzio) Reference Number: CP.PMN.139 Effective Date: 11.16.16 Last Review Date: 08.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of

More information

PROJECT TEAM. Karen Tilashalski, Alison Donoho, Marianne Drainer,

PROJECT TEAM. Karen Tilashalski, Alison Donoho, Marianne Drainer, PROJECT TEAM Karen Tilashalski, 618-205-8134 Alison Donoho, 618-205-8129 Marianne Drainer, 618-205-8154 SR-Narcan@Chestnut.org PURPOSE of Training Get an overview of the opioid epidemic Reduce the risk

More information

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. DISPENSING OR SELLING NALOXONE Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. UPDATED ON: April 21, 2017 Purpose The intent of this document is to provide

More information

Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine

Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine A 58 year old patient 20 year history of alcohol, opioid

More information

The Use of Naloxone in Workers Compensation. A Workers Compensation Continuing Education Course

The Use of Naloxone in Workers Compensation. A Workers Compensation Continuing Education Course The Use of Naloxone in Workers Compensation A Workers Compensation Continuing Education Course January 19, 2017 This course was previously presented on July 28, 2016. If you attended the course on that

More information

Package leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate

Package leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate Package leaflet: Information for the patient Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate Read all of this leaflet carefully before you start using this medicine because

More information

Calvert County Health Department Overdose Education and Naloxone Training

Calvert County Health Department Overdose Education and Naloxone Training Calvert County Health Department Overdose Education and Naloxone Training Maryland Overdose Response Program January 2015 Behavioral Health Administration Department of Health & Mental Hygiene dhmh.naloxone@maryland.gov

More information

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation. Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education

More information

2/20/2017 NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE DISCLOSURES LEARNING OBJECTIVES

2/20/2017 NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE DISCLOSURES LEARNING OBJECTIVES NALOXONE PRESCRIPTIONS FOR OVERDOSE: OUTSIDE OF MISUSE AND ABUSE Brett Badgley Snodgrass FNP-C, CPE, FACPP, FAANP Consultant/Independent Contractor: McNeil Pharmaceuticals, Purdue Pharmaceuticals Speaker's

More information

NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND

NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND Law Enforcement and Public Safety!!!!!!! Ariel Engelman NOPE-RI Coordinator 1 Opioids and Overdose in Rhode Island 2 Opioids and Overdose

More information

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry

More information

Management of Suspected Opioid Overdose With Naloxone by EMS Personnel

Management of Suspected Opioid Overdose With Naloxone by EMS Personnel Management of Suspected Opioid Overdose With Naloxone by EMS Personnel DATE: January 10, 2018 PRESENTED BY: Roger Chou, M. D., Director, Pacific Northwest Evidence - based Practice Center Purpose of Report

More information

PATIENT GROUP DIRECTION (PGD)

PATIENT GROUP DIRECTION (PGD) PATIENT GROUP DIRECTION (PGD) SUPPLY OF NALOXONE HYDROCHLORIDE INJECTION BY REGISTERED NURSES TO CLIENTS BEING RELEASED FROM HMP FORD Version Number: 01HMP Patient Group Direction originally drawn up by:

More information

Opioid Overdose Education and Naloxone Distribution

Opioid Overdose Education and Naloxone Distribution Opioid Overdose Education and Naloxone Distribution Emily Stoukides, PharmD PGY-2 Ambulatory Care Pharmacy Resident Nicole Brunet, PharmD, BCPP Clinical Pharmacy Specialist, Mental Health Disclosures Emily

More information

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region PREVENTING OPIATE OVERDOSES IN SCHOOLS Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region WHY IS THIS EVEN A QUESTION FOR SCHOOLS? In 2014, 467,000

More information

AN OVERVIEW OF THE PRESENTATION AND TREATMENT OF OPIOID OVERDOSE

AN OVERVIEW OF THE PRESENTATION AND TREATMENT OF OPIOID OVERDOSE AN OVERVIEW OF THE PRESENTATION AND TREATMENT OF OPIOID OVERDOSE Jasmine Carpenter, Pharm. D, BCPS, BCPP Clinical Pharmacy Specialist-PACT Mental Health Veterans Affairs Medical Center, Washington DC OBJECTIVES

More information

A Conversation on Fentanyl. School District 22 VERNON

A Conversation on Fentanyl. School District 22 VERNON A Conversation on Fentanyl School District 22 VERNON Why are we talking about this? In 2016 there were 922 unintentional overdose deaths in British Columbia 158 of those deaths occurred in Interior Health

More information

Overdose Prevention, Recognition & Response Education Train-the-Trainer

Overdose Prevention, Recognition & Response Education Train-the-Trainer Overdose Prevention, Recognition & Response Education Train-the-Trainer Bernie Lieving, MSW Overdose Prevention Education Coordinator Santa Fe Prevention Alliance & Office of Substance Abuse Prevention

More information

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold

More information

Naloxone in Schools. Training for School Staff

Naloxone in Schools. Training for School Staff Naloxone in Schools Training for School Staff Objectives Learn the signs and symptoms of opioid drug overdose Have the skills to administer naloxone Review the use of naloxone protocol in responding to

More information

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition Naloxone: Preventing Opioid Overdose in the Community Sharon Stancliff, MD Medical Director Harm Reduction Coalition DISCLOSURES Sharon Stancliff MD has nothing to disclose LEARNING OBJECTIVES 1. Discuss

More information

Welcome to the Opioid Overdose Prevention Project

Welcome to the Opioid Overdose Prevention Project Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize

More information

Opioid Safety: Focus on Furnishing Naloxone A GUIDE FOR CALIFORNIA COMMUNITY PHARMACISTS

Opioid Safety: Focus on Furnishing Naloxone A GUIDE FOR CALIFORNIA COMMUNITY PHARMACISTS Opioid Safety: Focus on Furnishing Naloxone A GUIDE FOR CALIFORNIA COMMUNITY PHARMACISTS Purpose of this guide Community pharmacists are uniquely poised to engage in efforts to reduce opioid misuse and

More information

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014 ANDREW M. CUOMO GOVERNOR STATE OF NEW YORK DIVISION OF CRIMINAL JUSTICE SERVICES Alfred E. Smith Office Building 80 South Swan Street Albany, New York 12210 http://criminaljustice.ny.gov MICHAEL C. GREEN

More information

Disclosure. State of Connecticut Naloxone Training Program. Introduction. Objectives. Background. Epidemiology 8/28/2018

Disclosure. State of Connecticut Naloxone Training Program. Introduction. Objectives. Background. Epidemiology 8/28/2018 State of Connecticut Naloxone Training Program Developed by: Department of Consumer Protection Drug Control Division Connecticut Pharmacists Association Department of Mental Health and Addiction Services

More information

Safe Practices and Action Items

Safe Practices and Action Items Safe Practices and Action Items Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine Case Study A 58 year

More information

A Bill Regular Session, 2015 SENATE BILL 880

A Bill Regular Session, 2015 SENATE BILL 880 Stricken language would be deleted from and underlined language would be added to present law. Act of the Regular Session 0 State of Arkansas 0th General Assembly As Engrossed: S// H// A Bill Regular Session,

More information

Opioids and Overdose 2017

Opioids and Overdose 2017 Opioids and Overdose 2017 This presentation is an introduction to: 1. Opioids, overdose and naloxone 2. How you can help A partnership of: Opioids A class of drugs taken for pain relief or euphoria. Prescribed

More information

PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray

PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray You and your family members or caregivers should read this Patient Information leaflet before an opioid emergency happens. This

More information

ORC Why Narcan? Things to know about Narcan. Things to know about Narcan 4/16/2018

ORC Why Narcan? Things to know about Narcan. Things to know about Narcan 4/16/2018 ORC 2925.61 Under the authority of Ohio Revised Code section 2925.61, peace officers that have been approved by their department to carry and administer (also known as naloxone), will carry the kits in

More information

Opioid Safety: Focus on Furnishing Naloxone

Opioid Safety: Focus on Furnishing Naloxone Opioid Safety: Focus on Furnishing Naloxone A GUIDE FOR CALIFORNIA COMMUNITY PHARMACISTS Talia Puzantian, PharmD, BCPP Associate Professor Keck Graduate Institute School of Pharmacy James J. Gasper, PharmD,

More information

Opioids 101. Washington Prevention Summit. Alison Newman, MPH November 6, 2018

Opioids 101. Washington Prevention Summit. Alison Newman, MPH November 6, 2018 Opioids 101 Washington Prevention Summit Alison Newman, MPH November 6, 2018 Opioids Class of drugs that work on the endorphin system. What are some examples? What are some of the risks? Opioid use disorder

More information

Medical Directive. Medical Director: Date Revised: January 1, Executive Director: Date Revised: January 1, 2019

Medical Directive. Medical Director: Date Revised: January 1, Executive Director: Date Revised: January 1, 2019 Medical Directive Title: Naloxone Administration Assigned Number: 025 Activation Date: January 1, 2019 Approval Signature & Date Review due by: December 1, 2020 Medical Director: Date Revised: January

More information

Opioids: Public Health Crisis Local Solutions: National Epidemic

Opioids: Public Health Crisis Local Solutions: National Epidemic Opioids: Public Health Crisis Local Solutions: National Epidemic Nancy McGraw, LCSW, MBA Public Health Director Sullivan County Public Health Services 50 Community Lane Liberty, NY 12754 Luis Alvarez,

More information

PHYSICIAN COMPETENCY FOR ADULT DEEP SEDATION (Ages 14 and older)

PHYSICIAN COMPETENCY FOR ADULT DEEP SEDATION (Ages 14 and older) Name Score PHYSICIAN COMPETENCY FOR ADULT DEEP SEDATION (Ages 14 and older) 1. Pre-procedure evaluation for moderate sedation should involve all of the following EXCEPT: a) Airway Exam b) Anesthetic history

More information

Sierra Sacramento Valley EMS Agency

Sierra Sacramento Valley EMS Agency Sierra Sacramento Valley EMS Agency BLS IN NALOXONE ADMINISTRATION OPTIONAL SKILL (UPDATED 06/2017) Acknowledgement: Siskiyou County SO - source of some slide content In order for PSFA, EMR or EMT personnel

More information

Naloxone Opioid Overdose Reversal Collaborative Drug Therapy Agreement

Naloxone Opioid Overdose Reversal Collaborative Drug Therapy Agreement Naloxone Opioid Overdose Reversal Collaborative Drug Therapy Agreement As a licensed health care provider authorized to prescribe medication in the State of Washington, I delegate prescriptive authority

More information

Bystander Naloxone Training Saves Lives

Bystander Naloxone Training Saves Lives Bystander Naloxone Training Saves Lives Graphic: Nytimes.com Death rates are spiraling out of control--for both prescription opioids and heroin! The scope of the problem Over the past decade, rates of

More information

Drug Overdose Prevention Program (DOPP)

Drug Overdose Prevention Program (DOPP) Drug Overdose Prevention Program (DOPP) GUIDELINES FOR IMPLEMENTATION [Type a quote from the documen T or the s ummary of an interesting p oint. You can position the text box anywhere in the document.

More information

SULLIVAN COUNTY Drug Abuse Prevention Task Force

SULLIVAN COUNTY Drug Abuse Prevention Task Force SULLIVAN COUNTY Drug Abuse Prevention Task Force Joseph A. Todora LMSW, Commissioner Sullivan County Division of Health ans Family Servies 17 Community Lane Liberty, NY 12754 MISSION: The mission of the

More information

Slide 1. Slide 2. Slide 3

Slide 1. Slide 2. Slide 3 Slide 1 Opioid Update: What s Happening at the National, State and Local Level? Susan DeVuyst-Miller, PharmD, AE-C Assistant Professor, Ferris State University Clinical Pharmacist, Cherry Health Services

More information

NALOXONE (NARCAN) POLICY

NALOXONE (NARCAN) POLICY POLICE DEPARTMENT NALOXONE (NARCAN) POLICY GENERAL ORDER NO. 2015-65 1.0 Policy This Order contains the following numbered sections: 2.0 Personnel Affected 3.0 Purpose 1.0 Policy 2.0 Personnel Affected

More information

ADMINISTRATIVE REQUIREMENT MANUAL EFFECTIVE DATE

ADMINISTRATIVE REQUIREMENT MANUAL EFFECTIVE DATE PURPOSE: I. To establish the minimum requirements for a first responder training course in first aid, which all first responders must take, in order to meet the requirements of M.G.L. c. 111, 201 and 105

More information

DECEMBER 7, 2017 THE OPIOID EPIDEMIC & THE UNIVERSITY S RESPONSE

DECEMBER 7, 2017 THE OPIOID EPIDEMIC & THE UNIVERSITY S RESPONSE DECEMBER 7, 2017 THE OPIOID EPIDEMIC & THE UNIVERSITY S RESPONSE Agenda Welcome & Introductions Trending Articles The Opioid Epidemic Key Updates What are Opioids? Chemically similar to heroin, prescribed

More information